Vicki L. Horton

Immunomodulating and antiviral activities of the imidazoquinoline S-28463

Mark A. Tomai, Sheila J. Gibson, Linda M. Imbertson et al. · Antiviral Research · 1995 · 130 citations

Medicine, Medicinal Chemistry, Pharmacology +13

A phase I clinical trial of imiquimod, an oral interferon inducer, administered daily

Philip Savage, Vicki L. Horton, J. Moore et al. · British Journal of Cancer · 1996 · 108 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +11

INDUCTION OF CYTOKINES IN CYNOMOLGUS MONKEYS BY THE IMMUNE RESPONSE MODIFIERS, IMIQUIMOD, S-27609 AND S-28463

Tamara L. Wagner, Vicki L. Horton, Gary L. Carlson et al. · Cytokine · 1997 · 75 citations

Life Sciences, Immunology, Pharmacology +11

Developmental phase-specific and dose-related teratogenic effects of ethylene glycol monomethyl ether in CD-1 mice

Vicki L. Horton, R. B. Sleet, J. A. JOHN-GREENE et al. · Toxicology and Applied Pharmacology · 1985 · 75 citations

Pharmacy, Toxicology, Developmental Toxicology +10

Physiologically based pharmacokinetic model for methanol in rats, monkeys, and humans

Vicki L. Horton, Mark Higuchi, Douglas E. Rickert · Toxicology and Applied Pharmacology · 1992 · 59 citations

Pharmacy, Pharmacokinetics, Pharmacology +11